These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 15151263

  • 1. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
    Kotzmann H, Yilmaz N, Lercher P, Riedl M, Schmidt A, Schuster E, Kreuzer S, Geyer G, Frisch H, Hörl WH, Mayer G, Luger A.
    Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [Abstract] [Full Text] [Related]

  • 4. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L.
    Eur J Endocrinol; 1997 Mar; 136(3):282-9. PubMed ID: 9100553
    [Abstract] [Full Text] [Related]

  • 5. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G.
    J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
    [Abstract] [Full Text] [Related]

  • 6. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
    Välimäki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E.
    Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
    [Abstract] [Full Text] [Related]

  • 7. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 8. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 9. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 10. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 11. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S, Di Rella F, Pivonello R, Di Somma C, Klain M, Maurelli L, Scarpa R, Colao A, Merola B, Lombardi G.
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [Abstract] [Full Text] [Related]

  • 12. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D, Zwolińska D, Bednorz R, Owczarek H, Szymańska A, Nahaczewska W.
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB, Hoeck HC, Kollerup G, Sørensen OH, Laurberg P, Feldt-Rasmussen U.
    Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
    [Abstract] [Full Text] [Related]

  • 15. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS.
    Eur J Endocrinol; 1996 Dec 15; 135(6):666-71. PubMed ID: 9025710
    [Abstract] [Full Text] [Related]

  • 17. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Dec 15; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.
    Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J.
    Clin Endocrinol (Oxf); 1998 May 15; 48(5):561-8. PubMed ID: 9666867
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ, Horber FF, Casez JP, Descoeudres C, Jaeger P.
    J Bone Miner Res; 1996 Jan 15; 11(1):96-104. PubMed ID: 8770702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.